On Nov. 5, 2025, join experts and patient voices for an in-depth discussion on breast implant illness, explant surgery, and the evolving science and regulation behind these devices. Hear real stories and learn what every woman and healthcare professional should know.

If you're considering breast reconstruction after breast cancer, this article is a must-read. Carol Small shares her powerful story of regret, health complications, and the critical importance of informed consent.

The PIP breast implant scandal is back in the news thanks to 60 Minutes Australia. Read why this is a powerful reminder that without transparency and independent oversight, the same mistakes can happen again.

A major government just said the quiet part out loud. Cosmetic procedures, including breast implants, come with real risks, and now the UK is launching an official inquiry to investigate. Learn how you can help before the July 4th deadline.

BISA was featured in the Tampa Bay Times alongside brave survivors of BIA-ALCL who gathered in Tampa to advocate for a ban on textured implants, stronger cancer warnings, and national cancer reporting.

If you’ve had breast surgery, you may have had GalaFLEX mesh or the “internal bra” placed in your body without knowing it. Here is what you need to know, why it matters, and what to do about it.

When device risks aren't clearly communicated, patients pay the price. In the wake of sweeping FDA layoffs, BISA spoke out in MedTech Dive about how delayed safety alerts and missing recall notices could put lives at risk.

The MDIC released new guidance on using real-world data. As momentum builds around direct patient input, BISA offers practical recommendations to turn this progress into lasting safety, trust, and meaningful partnerships.

As the medical community discusses the latest on breast implant associated cancers, members of the Breast Implant Safety Alliance (BISA) are gathering patients and survivors to help amplify their powerful stories.

Groundbreaking research confirms that silicone can migrate into the body, even without a rupture, triggering inflammation, immune responses, and autoimmune markers. What does this mean for women with implants? The findings may change everything. Read more to find out.

SAVE THE DATE! The 6th World Consensus Conference on BIA-ALCL will be held April 11-12, 2025, and will feature leading experts in breast surgery and implant safety discussing the latest research on breast implant-associated cancers.

Women with breast implants have long reported lingering health issues—even after removal. Now, groundbreaking research reveals a possible culprit: residual silicone particles left behind in the body, triggering chronic inflammation. Could this be the missing link to unexplained symptoms? Here’s what you need to know.

Recognized on February 13th, Breast Implant Illness (BII) Awareness Day serves as a critical moment to highlight the struggles faced by individuals experiencing health complications related to breast implants.

The FDA recently removed web pages about diversity in clinical trials, medical device safety, and more. Many experts are worried that this will make it harder for people to find important health information.

As we welcome 2025, we remain committed to transparency, patient safety, and empowering women with the information they deserve. Take a peek at the links we want to start highlighting in 2025.

While breast implants have long been promoted as safe and effective, Breast Implant Safety Alliance (BISA) was published in an article that shines a light on the safety concerns and asks an important question: Are breast implants really as safe as we think? 

Are breast implants as safe as we think, and why do we still question the safety? Members of the Breast Implant Safety Alliance (BISA) reviewed a new article examining the reputation of the FDA concerning the safety of breast implants.

Jennifer Cook began as a breast implant patient. She learned about the risk of developing cancer from breast implants at a school play. A few months later, she started experiencing symptoms and was diagnosed with a cancer called BIA-ALCL. In this video, she shares her experience as a patient and as an advocate.

Save the date for the 10th International Breast Surgery Workshop (IBSW) and the 6th World Consensus Conference on BIA-ALCL, scheduled for April 11-12, 2025, in Tampa, Florida,

BISA’s president Maria Gmitro and BISA’s advisor data advocate Madris Kinard of Device Events were both quoted in MedTech Dive, citing the optimism regarding Dr. Michelle Tarver’s appointment as the new Director of CDRH at FDA.